

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 6.23680553 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 6.23680553 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.23680553 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.23680553 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.23680553 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.23680553 |
| 7 | negative regulation of cell killing (GO:0031342) | 5.91809122 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.91809122 |
| 9 | positive regulation of interferon-alpha production (GO:0032727) | 5.53504012 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.32436099 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.32436099 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.27981718 |
| 13 | regulation of interferon-alpha production (GO:0032647) | 5.26212197 |
| 14 | negative T cell selection (GO:0043383) | 5.05177011 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.03286305 |
| 16 | response to type I interferon (GO:0034340) | 4.98220591 |
| 17 | type I interferon signaling pathway (GO:0060337) | 4.97845846 |
| 18 | cellular response to type I interferon (GO:0071357) | 4.97845846 |
| 19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.88794856 |
| 20 | negative thymic T cell selection (GO:0045060) | 4.80078962 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.57054968 |
| 22 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.52965613 |
| 23 | response to host immune response (GO:0052572) | 4.52965613 |
| 24 | response to interferon-alpha (GO:0035455) | 4.40081293 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 4.26807977 |
| 26 | response to interleukin-15 (GO:0070672) | 4.18432848 |
| 27 | cellular response to interleukin-15 (GO:0071350) | 4.17336640 |
| 28 | negative regulation of T cell mediated immunity (GO:0002710) | 4.16875005 |
| 29 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.06917905 |
| 30 | response to host (GO:0075136) | 4.06917905 |
| 31 | response to host defenses (GO:0052200) | 4.06917905 |
| 32 | response to peptidoglycan (GO:0032494) | 4.03703745 |
| 33 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.03098176 |
| 34 | positive T cell selection (GO:0043368) | 4.02512510 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 4.01767171 |
| 36 | positive regulation of antigen processing and presentation (GO:0002579) | 3.96444954 |
| 37 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.96351068 |
| 38 | positive regulation of interferon-beta production (GO:0032728) | 3.89916820 |
| 39 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.79439646 |
| 40 | positive thymic T cell selection (GO:0045059) | 3.77035240 |
| 41 | cellular response to interferon-alpha (GO:0035457) | 3.74274522 |
| 42 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.73186847 |
| 43 | T cell selection (GO:0045058) | 3.69590284 |
| 44 | thymic T cell selection (GO:0045061) | 3.66155592 |
| 45 | microglial cell activation (GO:0001774) | 3.64741926 |
| 46 | leukocyte aggregation (GO:0070486) | 3.62759286 |
| 47 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.61925336 |
| 48 | neutrophil activation involved in immune response (GO:0002283) | 3.59046999 |
| 49 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.55672540 |
| 50 | regulation of T cell tolerance induction (GO:0002664) | 3.50266062 |
| 51 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.48427286 |
| 52 | interferon-gamma production (GO:0032609) | 3.47231912 |
| 53 | positive regulation of tolerance induction (GO:0002645) | 3.44802378 |
| 54 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.44739394 |
| 55 | cellular response to virus (GO:0098586) | 3.42698383 |
| 56 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.40235020 |
| 57 | regulation of antigen processing and presentation (GO:0002577) | 3.37525756 |
| 58 | activated T cell proliferation (GO:0050798) | 3.36325191 |
| 59 | negative regulation of viral genome replication (GO:0045071) | 3.35966486 |
| 60 | low-density lipoprotein particle clearance (GO:0034383) | 3.35124916 |
| 61 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.33892650 |
| 62 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.33144851 |
| 63 | I-kappaB phosphorylation (GO:0007252) | 3.33081154 |
| 64 | regulation of cholesterol storage (GO:0010885) | 3.33028235 |
| 65 | tolerance induction (GO:0002507) | 3.29439697 |
| 66 | regulation of tolerance induction (GO:0002643) | 3.28853286 |
| 67 | response to muramyl dipeptide (GO:0032495) | 3.27657419 |
| 68 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.26814350 |
| 69 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.26404298 |
| 70 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.24301716 |
| 71 | regulation of regulatory T cell differentiation (GO:0045589) | 3.23694843 |
| 72 | positive regulation of granulocyte differentiation (GO:0030854) | 3.17355713 |
| 73 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.17309450 |
| 74 | cellular response to interferon-beta (GO:0035458) | 3.17206979 |
| 75 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.16011700 |
| 76 | T cell migration (GO:0072678) | 3.15964266 |
| 77 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.14926233 |
| 78 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.14028416 |
| 79 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.09778364 |
| 80 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.07679078 |
| 81 | macrophage activation (GO:0042116) | 3.07631236 |
| 82 | regulation of necroptotic process (GO:0060544) | 3.05333200 |
| 83 | positive regulation of interleukin-12 production (GO:0032735) | 3.05227459 |
| 84 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.03887441 |
| 85 | T-helper 1 type immune response (GO:0042088) | 3.03212747 |
| 86 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.02257246 |
| 87 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.01828902 |
| 88 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.01828902 |
| 89 | response to interferon-beta (GO:0035456) | 2.99892980 |
| 90 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.99656847 |
| 91 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.97844720 |
| 92 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.97023571 |
| 93 | detection of molecule of bacterial origin (GO:0032490) | 2.95847022 |
| 94 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.94348627 |
| 95 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.94296234 |
| 96 | lymphocyte migration (GO:0072676) | 2.90712530 |
| 97 | B cell receptor signaling pathway (GO:0050853) | 2.89765590 |
| 98 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.87600227 |
| 99 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.87458321 |
| 100 | respiratory burst (GO:0045730) | 2.86833364 |
| 101 | negative regulation of type 2 immune response (GO:0002829) | 2.86090864 |
| 102 | positive regulation of macrophage cytokine production (GO:0060907) | 2.85589760 |
| 103 | regulation of interferon-beta production (GO:0032648) | 2.84962671 |
| 104 | myeloid cell activation involved in immune response (GO:0002275) | 2.84367144 |
| 105 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.84045643 |
| 106 | regulation of gamma-delta T cell activation (GO:0046643) | 2.83756516 |
| 107 | detection of other organism (GO:0098543) | 2.83415551 |
| 108 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.82335106 |
| 109 | regulation of RIG-I signaling pathway (GO:0039535) | 2.82023256 |
| 110 | B cell mediated immunity (GO:0019724) | 2.81480438 |
| 111 | cellular response to interferon-gamma (GO:0071346) | 2.81405560 |
| 112 | germinal center formation (GO:0002467) | 2.80584668 |
| 113 | T cell receptor signaling pathway (GO:0050852) | 2.79789894 |
| 114 | regulation of B cell differentiation (GO:0045577) | 2.79754686 |
| 115 | granulocyte activation (GO:0036230) | 2.78765873 |
| 116 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.76518168 |
| 117 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.76289204 |
| 118 | cellular response to exogenous dsRNA (GO:0071360) | 2.76287329 |
| 119 | defense response to virus (GO:0051607) | 2.75719513 |
| 120 | neutrophil activation (GO:0042119) | 2.75215361 |
| 121 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.72891521 |
| 122 | NIK/NF-kappaB signaling (GO:0038061) | 2.71453148 |
| 123 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.70169124 |
| 124 | myeloid dendritic cell differentiation (GO:0043011) | 2.70110202 |
| 125 | regulation of cell killing (GO:0031341) | 2.69435597 |
| 126 | cellular extravasation (GO:0045123) | 2.69044130 |
| 127 | detection of bacterium (GO:0016045) | 2.68258760 |
| 128 | regulation of interleukin-12 production (GO:0032655) | 2.67420590 |
| 129 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.67075926 |
| 130 | negative regulation of interleukin-12 production (GO:0032695) | 2.66656501 |
| 131 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.66286943 |
| 132 | substrate-dependent cell migration (GO:0006929) | 2.65281904 |
| 133 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.65173402 |
| 134 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.63296342 |
| 135 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.63148211 |
| 136 | regulation of mononuclear cell migration (GO:0071675) | 2.62540099 |
| 137 | dendritic cell migration (GO:0036336) | 2.59961033 |
| 138 | negative regulation of adaptive immune response (GO:0002820) | 2.59866685 |
| 139 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.59646515 |
| 140 | positive regulation of lipid storage (GO:0010884) | 2.57896721 |
| 141 | positive regulation of type 2 immune response (GO:0002830) | 2.57848572 |
| 142 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.57744216 |
| 143 | natural killer cell mediated immunity (GO:0002228) | 2.56151753 |
| 144 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.56151753 |
| 145 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.55618901 |
| 146 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.55274798 |
| 147 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.55015678 |
| 148 | hypotonic response (GO:0006971) | 2.54090556 |
| 149 | positive regulation of humoral immune response (GO:0002922) | 2.53677780 |
| 150 | defense response to protozoan (GO:0042832) | 2.53223370 |
| 151 | myeloid dendritic cell activation (GO:0001773) | 2.53170093 |
| 152 | lymph node development (GO:0048535) | 2.53022282 |
| 153 | positive regulation of isotype switching (GO:0045830) | 2.52943990 |
| 154 | hepatocyte apoptotic process (GO:0097284) | 2.52851021 |
| 155 | pinocytosis (GO:0006907) | 2.52826039 |
| 156 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.52824159 |
| 157 | lymphocyte chemotaxis (GO:0048247) | 2.52799379 |
| 158 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.52281092 |
| 159 | negative regulation of B cell proliferation (GO:0030889) | 2.51689080 |
| 160 | regulation of response to interferon-gamma (GO:0060330) | 2.51530101 |
| 161 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.51248201 |
| 162 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.51248201 |
| 163 | positive regulation of interleukin-2 production (GO:0032743) | 2.51228111 |
| 164 | positive regulation of macrophage differentiation (GO:0045651) | 2.50804250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.86208995 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.94515767 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.60356258 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.04555059 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.51322274 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.89213934 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.84989574 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.42847558 |
| 9 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.27516490 |
| 10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.03289355 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.88442534 |
| 12 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.64870473 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.63100250 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.43430718 |
| 15 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.42254152 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.32862995 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.31549227 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.22777592 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.21873628 |
| 20 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.02231495 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.99607775 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.96552400 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.94007406 |
| 24 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.91796872 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.78606197 |
| 26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.77432875 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.73864872 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73813374 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71663882 |
| 30 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.66354422 |
| 31 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.62464168 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.57153926 |
| 33 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57080333 |
| 34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.56022068 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55318081 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.54259355 |
| 37 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53702748 |
| 38 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.50006602 |
| 39 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.49152557 |
| 40 | * MAF_26560356_Chip-Seq_TH1_Human | 1.42924921 |
| 41 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.42275552 |
| 42 | * MYB_26560356_Chip-Seq_TH2_Human | 1.37324862 |
| 43 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36012855 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.33372828 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32663520 |
| 46 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.23071419 |
| 47 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19410244 |
| 48 | * MYB_26560356_Chip-Seq_TH1_Human | 1.17581364 |
| 49 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14963273 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14361843 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.13131948 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13018664 |
| 53 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12847611 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10360941 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09423775 |
| 56 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.08709971 |
| 57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07402915 |
| 58 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05159717 |
| 59 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.04081734 |
| 60 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01370621 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01202865 |
| 62 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93503743 |
| 63 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92697280 |
| 64 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92640072 |
| 65 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.92371320 |
| 66 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.92162583 |
| 67 | MYC_22102868_ChIP-Seq_BL_Human | 0.91616869 |
| 68 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90635114 |
| 69 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.90297003 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90008703 |
| 71 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89378564 |
| 72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.89349989 |
| 73 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89134846 |
| 74 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.88933044 |
| 75 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87683821 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87527204 |
| 77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86257590 |
| 78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85691045 |
| 79 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85671604 |
| 80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85668178 |
| 81 | UTX_26944678_Chip-Seq_JUKART_Human | 0.84954171 |
| 82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84530639 |
| 83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84091911 |
| 84 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.83856458 |
| 85 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83604478 |
| 86 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.83280805 |
| 87 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82515710 |
| 88 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.82279229 |
| 89 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.81786230 |
| 90 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81505199 |
| 91 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81505199 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81196452 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81164391 |
| 94 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80149715 |
| 95 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79559801 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79189213 |
| 97 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.79170051 |
| 98 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.79053139 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.79053139 |
| 100 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.78635896 |
| 101 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.78635896 |
| 102 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.78069468 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77725660 |
| 104 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77510284 |
| 105 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.77240267 |
| 106 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76372849 |
| 107 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75486684 |
| 108 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.75199739 |
| 109 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.74931275 |
| 110 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.74729254 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.74678951 |
| 112 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.74435809 |
| 113 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73857370 |
| 114 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.73547570 |
| 115 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.73277151 |
| 116 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.70636313 |
| 117 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.70442764 |
| 118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69150867 |
| 119 | MAF_26560356_Chip-Seq_TH2_Human | 0.69005852 |
| 120 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.68794731 |
| 121 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67274069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.00376607 |
| 2 | MP0003724_increased_susceptibility_to | 3.88145472 |
| 3 | MP0003303_peritoneal_inflammation | 3.36131739 |
| 4 | MP0009785_altered_susceptibility_to | 3.22935862 |
| 5 | MP0003436_decreased_susceptibility_to | 3.02005183 |
| 6 | MP0004510_myositis | 2.94139561 |
| 7 | MP0001790_abnormal_immune_system | 2.85785276 |
| 8 | MP0005387_immune_system_phenotype | 2.85785276 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.72437277 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.70306602 |
| 11 | MP0002419_abnormal_innate_immunity | 2.63255502 |
| 12 | MP0005025_abnormal_response_to | 2.60760880 |
| 13 | MP0000685_abnormal_immune_system | 2.44930872 |
| 14 | MP0006082_CNS_inflammation | 2.39795472 |
| 15 | MP0001800_abnormal_humoral_immune | 2.34518439 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.32328148 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.23825377 |
| 18 | MP0002723_abnormal_immune_serum | 2.21740120 |
| 19 | MP0005671_abnormal_response_to | 2.16323384 |
| 20 | MP0001533_abnormal_skeleton_physiology | 2.06949273 |
| 21 | MP0000343_altered_response_to | 2.06821570 |
| 22 | MP0003828_pulmonary_edema | 1.99007423 |
| 23 | MP0003300_gastrointestinal_ulcer | 1.95086558 |
| 24 | MP0001819_abnormal_immune_cell | 1.93125873 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.89736063 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.88959724 |
| 27 | MP0001879_abnormal_lymphatic_vessel | 1.82250055 |
| 28 | MP0005167_abnormal_blood-brain_barrier | 1.81564811 |
| 29 | MP0008438_abnormal_cutaneous_collagen | 1.76136363 |
| 30 | MP0009278_abnormal_bone_marrow | 1.75495161 |
| 31 | MP0004947_skin_inflammation | 1.72555046 |
| 32 | MP0003448_altered_tumor_morphology | 1.70708352 |
| 33 | MP0002006_tumorigenesis | 1.66630436 |
| 34 | MP0004883_abnormal_blood_vessel | 1.65488219 |
| 35 | MP0001853_heart_inflammation | 1.64461954 |
| 36 | MP0009764_decreased_sensitivity_to | 1.63180442 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.60662557 |
| 38 | MP0008469_abnormal_protein_level | 1.58864261 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.58813252 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.55469518 |
| 41 | MP0002405_respiratory_system_inflammati | 1.55377771 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.52944086 |
| 43 | MP0003866_abnormal_defecation | 1.51886178 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.51324248 |
| 45 | MP0010368_abnormal_lymphatic_system | 1.47139516 |
| 46 | MP0004381_abnormal_hair_follicle | 1.45504853 |
| 47 | MP0004130_abnormal_muscle_cell | 1.41548153 |
| 48 | MP0006054_spinal_hemorrhage | 1.40319873 |
| 49 | MP0000716_abnormal_immune_system | 1.39557607 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.36850243 |
| 51 | MP0008260_abnormal_autophagy | 1.34766676 |
| 52 | MP0001958_emphysema | 1.32904655 |
| 53 | MP0003566_abnormal_cell_adhesion | 1.31814521 |
| 54 | MP0001851_eye_inflammation | 1.30944461 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.28602253 |
| 56 | MP0003690_abnormal_glial_cell | 1.28250461 |
| 57 | MP0003075_altered_response_to | 1.28129649 |
| 58 | MP0002398_abnormal_bone_marrow | 1.27605081 |
| 59 | MP0005310_abnormal_salivary_gland | 1.26497946 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.21985552 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.21985552 |
| 62 | MP0000767_abnormal_smooth_muscle | 1.19544150 |
| 63 | MP0005670_abnormal_white_adipose | 1.19354548 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.16797487 |
| 65 | MP0003091_abnormal_cell_migration | 1.15550312 |
| 66 | MP0000604_amyloidosis | 1.13421168 |
| 67 | MP0003045_fibrosis | 1.12286131 |
| 68 | MP0005164_abnormal_response_to | 1.11896507 |
| 69 | MP0009840_abnormal_foam_cell | 1.11334078 |
| 70 | MP0002429_abnormal_blood_cell | 1.10460068 |
| 71 | MP0000249_abnormal_blood_vessel | 1.09420593 |
| 72 | MP0005451_abnormal_body_composition | 1.08880687 |
| 73 | MP0002933_joint_inflammation | 1.08099125 |
| 74 | MP0000689_abnormal_spleen_morphology | 1.06452659 |
| 75 | MP0009763_increased_sensitivity_to | 1.00968445 |
| 76 | MP0005390_skeleton_phenotype | 0.99992754 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 0.96910144 |
| 78 | MP0008775_abnormal_heart_ventricle | 0.96358790 |
| 79 | MP0000569_abnormal_digit_pigmentation | 0.96249453 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 0.95617770 |
| 81 | MP0002396_abnormal_hematopoietic_system | 0.94938001 |
| 82 | MP0001348_abnormal_lacrimal_gland | 0.94048484 |
| 83 | MP0003763_abnormal_thymus_physiology | 0.93766993 |
| 84 | MP0002722_abnormal_immune_system | 0.93548950 |
| 85 | MP0004272_abnormal_basement_membrane | 0.93048140 |
| 86 | MP0002009_preneoplasia | 0.92764193 |
| 87 | MP0002254_reproductive_system_inflammat | 0.91887666 |
| 88 | MP0009333_abnormal_splenocyte_physiolog | 0.91814657 |
| 89 | MP0002168_other_aberrant_phenotype | 0.91795831 |
| 90 | MP0005503_abnormal_tendon_morphology | 0.90944674 |
| 91 | MP0004084_abnormal_cardiac_muscle | 0.89329328 |
| 92 | MP0000858_altered_metastatic_potential | 0.89306225 |
| 93 | MP0005165_increased_susceptibility_to | 0.88489669 |
| 94 | MP0001542_abnormal_bone_strength | 0.88130398 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 0.87538356 |
| 96 | MP0004185_abnormal_adipocyte_glucose | 0.86566353 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.85640836 |
| 98 | MP0001873_stomach_inflammation | 0.85107489 |
| 99 | MP0005166_decreased_susceptibility_to | 0.83663668 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.82449745 |
| 101 | MP0004808_abnormal_hematopoietic_stem | 0.82117835 |
| 102 | MP0002332_abnormal_exercise_endurance | 0.81781491 |
| 103 | MP0003795_abnormal_bone_structure | 0.80257994 |
| 104 | MP0010352_gastrointestinal_tract_polyps | 0.80204146 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.78089467 |
| 106 | MP0001544_abnormal_cardiovascular_syste | 0.77517172 |
| 107 | MP0005385_cardiovascular_system_phenoty | 0.77517172 |
| 108 | MP0009115_abnormal_fat_cell | 0.76941294 |
| 109 | MP0003705_abnormal_hypodermis_morpholog | 0.75505736 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.74425317 |
| 111 | MP0005275_abnormal_skin_tensile | 0.73884775 |
| 112 | MP0003183_abnormal_peptide_metabolism | 0.73650465 |
| 113 | MP0008004_abnormal_stomach_pH | 0.73403983 |
| 114 | MP0003279_aneurysm | 0.71112481 |
| 115 | MP0000465_gastrointestinal_hemorrhage | 0.70384581 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.69793379 |
| 117 | MP0010307_abnormal_tumor_latency | 0.69198810 |
| 118 | MP0000750_abnormal_muscle_regeneration | 0.67028978 |
| 119 | MP0003950_abnormal_plasma_membrane | 0.64882272 |
| 120 | MP0002133_abnormal_respiratory_system | 0.64635808 |
| 121 | MP0005388_respiratory_system_phenotype | 0.64635808 |
| 122 | MP0005075_abnormal_melanosome_morpholog | 0.64443819 |
| 123 | MP0003646_muscle_fatigue | 0.63734441 |
| 124 | MP0002060_abnormal_skin_morphology | 0.63058043 |
| 125 | MP0005023_abnormal_wound_healing | 0.62486367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.80607504 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.53742122 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.50076975 |
| 4 | Abnormality of T cell number (HP:0011839) | 5.46844049 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.88230004 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 4.31291644 |
| 7 | Myositis (HP:0100614) | 4.30352116 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.29704832 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.28818224 |
| 10 | Chronic otitis media (HP:0000389) | 4.26092664 |
| 11 | Orchitis (HP:0100796) | 4.19748997 |
| 12 | Autoimmune thrombocytopenia (HP:0001973) | 4.19659756 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.19050130 |
| 14 | Hematochezia (HP:0002573) | 4.10169739 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 3.76885090 |
| 16 | Abnormality of the nasal mucosa (HP:0000433) | 3.69500488 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.66813792 |
| 18 | Optic neuritis (HP:0100653) | 3.66813792 |
| 19 | Spontaneous hematomas (HP:0007420) | 3.61721729 |
| 20 | Abnormality of T cells (HP:0002843) | 3.56674415 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.55394654 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.55051736 |
| 23 | Basal ganglia calcification (HP:0002135) | 3.33676079 |
| 24 | Gastrointestinal infarctions (HP:0005244) | 3.30855186 |
| 25 | Vasculitis (HP:0002633) | 3.30555267 |
| 26 | Recurrent fungal infections (HP:0002841) | 3.29280481 |
| 27 | Gingivitis (HP:0000230) | 3.28382562 |
| 28 | Recurrent viral infections (HP:0004429) | 3.26218802 |
| 29 | Recurrent skin infections (HP:0001581) | 3.25409636 |
| 30 | Prostate neoplasm (HP:0100787) | 3.25017309 |
| 31 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.21675827 |
| 32 | Tetraparesis (HP:0002273) | 3.19794854 |
| 33 | Myocardial infarction (HP:0001658) | 3.18659669 |
| 34 | Porencephaly (HP:0002132) | 3.13079590 |
| 35 | Nasal polyposis (HP:0100582) | 3.07608450 |
| 36 | Glomerulonephritis (HP:0000099) | 2.89595932 |
| 37 | Pulmonary infiltrates (HP:0002113) | 2.84581943 |
| 38 | Stomatitis (HP:0010280) | 2.83900940 |
| 39 | Increased IgM level (HP:0003496) | 2.81751086 |
| 40 | Interstitial pulmonary disease (HP:0006530) | 2.80869508 |
| 41 | Spondylolisthesis (HP:0003302) | 2.79053530 |
| 42 | Thick nail (HP:0001805) | 2.77295283 |
| 43 | Axonal loss (HP:0003447) | 2.75196955 |
| 44 | Nephritis (HP:0000123) | 2.74832413 |
| 45 | Aortic aneurysm (HP:0004942) | 2.70665772 |
| 46 | Esophageal varix (HP:0002040) | 2.70060617 |
| 47 | Obstructive lung disease (HP:0006536) | 2.67338043 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.67338043 |
| 49 | Abnormality of eosinophils (HP:0001879) | 2.64430877 |
| 50 | Colitis (HP:0002583) | 2.64398778 |
| 51 | Loss of speech (HP:0002371) | 2.64152538 |
| 52 | IgG deficiency (HP:0004315) | 2.61116006 |
| 53 | Encephalitis (HP:0002383) | 2.60745467 |
| 54 | Recurrent cutaneous fungal infections (HP:0011370) | 2.60669261 |
| 55 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.60669261 |
| 56 | Cellulitis (HP:0100658) | 2.58368757 |
| 57 | Recurrent bronchitis (HP:0002837) | 2.57885780 |
| 58 | Chronic diarrhea (HP:0002028) | 2.53761803 |
| 59 | Keratoconjunctivitis sicca (HP:0001097) | 2.53263150 |
| 60 | Hemoptysis (HP:0002105) | 2.49454911 |
| 61 | Hypergammaglobulinemia (HP:0010702) | 2.48867208 |
| 62 | Arterial thrombosis (HP:0004420) | 2.48652004 |
| 63 | Pustule (HP:0200039) | 2.46134468 |
| 64 | Granulocytopenia (HP:0001913) | 2.43757048 |
| 65 | Aortic dissection (HP:0002647) | 2.42275796 |
| 66 | Severe combined immunodeficiency (HP:0004430) | 2.40409475 |
| 67 | Polycythemia (HP:0001901) | 2.40137911 |
| 68 | Inflammation of the large intestine (HP:0002037) | 2.38288898 |
| 69 | Chronic sinusitis (HP:0011109) | 2.37351548 |
| 70 | Increased IgE level (HP:0003212) | 2.35635289 |
| 71 | Osteolytic defects of the hand bones (HP:0009699) | 2.31883031 |
| 72 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.31883031 |
| 73 | Periodontitis (HP:0000704) | 2.31609810 |
| 74 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.31495155 |
| 75 | Dysostosis multiplex (HP:0000943) | 2.30675363 |
| 76 | Chest pain (HP:0100749) | 2.29940009 |
| 77 | Abnormality of T cell physiology (HP:0011840) | 2.29838524 |
| 78 | Vascular tortuosity (HP:0004948) | 2.29503329 |
| 79 | Pulmonary artery stenosis (HP:0004415) | 2.28129514 |
| 80 | Subacute progressive viral hepatitis (HP:0006572) | 2.27876528 |
| 81 | Disinhibition (HP:0000734) | 2.27019118 |
| 82 | Leukocytosis (HP:0001974) | 2.26746407 |
| 83 | Emphysema (HP:0002097) | 2.25783662 |
| 84 | Keratoconjunctivitis (HP:0001096) | 2.25709569 |
| 85 | Joint hemorrhage (HP:0005261) | 2.23240538 |
| 86 | Arterial tortuosity (HP:0005116) | 2.21488836 |
| 87 | Glucose intolerance (HP:0000833) | 2.20912498 |
| 88 | Autoimmune hemolytic anemia (HP:0001890) | 2.20817001 |
| 89 | Gingival bleeding (HP:0000225) | 2.20336888 |
| 90 | Dilatation of the ascending aorta (HP:0005111) | 2.14728269 |
| 91 | Meningitis (HP:0001287) | 2.14643653 |
| 92 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.13955376 |
| 93 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.13955376 |
| 94 | Abnormality of glycolipid metabolism (HP:0010969) | 2.13955376 |
| 95 | Panhypogammaglobulinemia (HP:0003139) | 2.13118546 |
| 96 | Gastrointestinal inflammation (HP:0004386) | 2.12033755 |
| 97 | Urticaria (HP:0001025) | 2.11961022 |
| 98 | Lymphopenia (HP:0001888) | 2.10724765 |
| 99 | Osteomyelitis (HP:0002754) | 2.10507848 |
| 100 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.09097399 |
| 101 | Protrusio acetabuli (HP:0003179) | 2.08782552 |
| 102 | IgA deficiency (HP:0002720) | 2.08763846 |
| 103 | Epistaxis (HP:0000421) | 2.07816148 |
| 104 | Mucopolysacchariduria (HP:0008155) | 2.07616425 |
| 105 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.07616425 |
| 106 | Joint swelling (HP:0001386) | 2.07042353 |
| 107 | Milia (HP:0001056) | 2.06758530 |
| 108 | Hepatosplenomegaly (HP:0001433) | 2.06194494 |
| 109 | Thyroiditis (HP:0100646) | 2.05640409 |
| 110 | Prolonged bleeding time (HP:0003010) | 2.03976349 |
| 111 | Complement deficiency (HP:0004431) | 2.03841488 |
| 112 | Eosinophilia (HP:0001880) | 2.03497431 |
| 113 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.03289079 |
| 114 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.02053513 |
| 115 | Bronchitis (HP:0012387) | 2.00656786 |
| 116 | Pulmonary embolism (HP:0002204) | 1.99762349 |
| 117 | Amyloidosis (HP:0011034) | 1.99611687 |
| 118 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99368394 |
| 119 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99368394 |
| 120 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99368394 |
| 121 | Absent frontal sinuses (HP:0002688) | 1.99180953 |
| 122 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.99115083 |
| 123 | Hemorrhage of the eye (HP:0011885) | 1.98790753 |
| 124 | Papilledema (HP:0001085) | 1.97713942 |
| 125 | Recurrent lower respiratory tract infections (HP:0002783) | 1.94781784 |
| 126 | Conjunctival telangiectasia (HP:0000524) | 1.94558417 |
| 127 | Syringomyelia (HP:0003396) | 1.93979848 |
| 128 | Spinal cord lesions (HP:0100561) | 1.93979848 |
| 129 | Recurrent pneumonia (HP:0006532) | 1.93693238 |
| 130 | Peritonitis (HP:0002586) | 1.89418414 |
| 131 | Frequent falls (HP:0002359) | 1.87679996 |
| 132 | Increased connective tissue (HP:0009025) | 1.87106561 |
| 133 | Asymmetric septal hypertrophy (HP:0001670) | 1.86744487 |
| 134 | Papilloma (HP:0012740) | 1.86445654 |
| 135 | Verrucae (HP:0200043) | 1.86445654 |
| 136 | Nausea (HP:0002018) | 1.86365362 |
| 137 | Skin ulcer (HP:0200042) | 1.85179435 |
| 138 | Atrophic scars (HP:0001075) | 1.84350689 |
| 139 | Abnormality of the fingertips (HP:0001211) | 1.83706120 |
| 140 | Anorexia (HP:0002039) | 1.83070351 |
| 141 | Viral hepatitis (HP:0006562) | 1.81285080 |
| 142 | Slow saccadic eye movements (HP:0000514) | 1.78914371 |
| 143 | Glomerulopathy (HP:0100820) | 1.78704610 |
| 144 | Gangrene (HP:0100758) | 1.78256407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TYK2 | 3.94617751 |
| 2 | MAP3K14 | 3.44439226 |
| 3 | TIE1 | 3.35279986 |
| 4 | TBK1 | 3.25397027 |
| 5 | IKBKE | 3.11104080 |
| 6 | JAK1 | 2.92434643 |
| 7 | JAK3 | 2.79819872 |
| 8 | BLK | 2.78950846 |
| 9 | KIT | 2.72228111 |
| 10 | IRAK3 | 2.62518003 |
| 11 | IRAK4 | 2.58579032 |
| 12 | FGFR4 | 2.53645228 |
| 13 | TGFBR2 | 2.35648379 |
| 14 | PRPF4B | 2.30252510 |
| 15 | EPHB1 | 2.29028184 |
| 16 | ERN1 | 2.23668468 |
| 17 | MAP4K1 | 2.23455613 |
| 18 | KDR | 2.21943857 |
| 19 | FGFR3 | 2.01658304 |
| 20 | IKBKB | 1.97046826 |
| 21 | RIPK4 | 1.82718186 |
| 22 | EPHA3 | 1.81306191 |
| 23 | MAP3K13 | 1.80596428 |
| 24 | CSK | 1.79433914 |
| 25 | TTN | 1.68045670 |
| 26 | TXK | 1.65986083 |
| 27 | GRK6 | 1.65324737 |
| 28 | RIPK1 | 1.60598755 |
| 29 | CAMK1D | 1.44842108 |
| 30 | CAMKK2 | 1.35916423 |
| 31 | PIK3CG | 1.34181519 |
| 32 | HCK | 1.27689309 |
| 33 | FES | 1.23997403 |
| 34 | ZAP70 | 1.23088164 |
| 35 | JAK2 | 1.21265419 |
| 36 | CHUK | 1.17662514 |
| 37 | IRAK1 | 1.16065087 |
| 38 | LCK | 1.06708365 |
| 39 | CDC42BPA | 1.05882548 |
| 40 | DMPK | 1.05140519 |
| 41 | CAMK1G | 1.04777542 |
| 42 | CSF1R | 1.02339194 |
| 43 | SYK | 1.01625431 |
| 44 | FGR | 0.97330343 |
| 45 | PBK | 0.96178526 |
| 46 | STK38 | 0.95948638 |
| 47 | NEK9 | 0.95086555 |
| 48 | MAPK7 | 0.92740738 |
| 49 | PDGFRA | 0.91173977 |
| 50 | MARK3 | 0.91063333 |
| 51 | BMPR2 | 0.89282729 |
| 52 | MELK | 0.88849782 |
| 53 | TEC | 0.88827518 |
| 54 | TAOK3 | 0.83926647 |
| 55 | BTK | 0.83618392 |
| 56 | CDK12 | 0.81639242 |
| 57 | HIPK2 | 0.80734089 |
| 58 | PTK6 | 0.80251453 |
| 59 | NLK | 0.79981404 |
| 60 | STK10 | 0.79788285 |
| 61 | TRIB3 | 0.78806396 |
| 62 | MARK2 | 0.78475712 |
| 63 | MAP3K7 | 0.78122909 |
| 64 | LYN | 0.77982988 |
| 65 | MAP2K3 | 0.76757618 |
| 66 | TRPM7 | 0.76468370 |
| 67 | MAPK11 | 0.75480906 |
| 68 | PIM2 | 0.75187298 |
| 69 | MOS | 0.74083791 |
| 70 | EIF2AK2 | 0.73608252 |
| 71 | GRK7 | 0.73011810 |
| 72 | ITK | 0.72541550 |
| 73 | DDR2 | 0.71692591 |
| 74 | PKN1 | 0.69503016 |
| 75 | PRKD2 | 0.68560806 |
| 76 | AKT3 | 0.66186853 |
| 77 | TGFBR1 | 0.65496662 |
| 78 | MST1R | 0.64090222 |
| 79 | SIK2 | 0.63570609 |
| 80 | CDK6 | 0.62848082 |
| 81 | MAP3K10 | 0.62583661 |
| 82 | BMX | 0.62333072 |
| 83 | MAP3K2 | 0.62287948 |
| 84 | SIK1 | 0.61639455 |
| 85 | MAP3K3 | 0.61363436 |
| 86 | EGFR | 0.59937952 |
| 87 | PRKAA2 | 0.59403885 |
| 88 | MAP3K5 | 0.59267603 |
| 89 | WNK1 | 0.56871752 |
| 90 | MATK | 0.55870155 |
| 91 | RPS6KA4 | 0.55710669 |
| 92 | ABL1 | 0.55644606 |
| 93 | SGK2 | 0.54560652 |
| 94 | CAMKK1 | 0.51305141 |
| 95 | TNK2 | 0.50649242 |
| 96 | PIM1 | 0.50475204 |
| 97 | PRKCQ | 0.49764965 |
| 98 | NUAK1 | 0.49339629 |
| 99 | LRRK2 | 0.49222230 |
| 100 | PRKCH | 0.48869298 |
| 101 | YES1 | 0.48565989 |
| 102 | GRK5 | 0.47635884 |
| 103 | PTK2B | 0.47456811 |
| 104 | IRAK2 | 0.47235146 |
| 105 | GSK3A | 0.46526494 |
| 106 | PDGFRB | 0.45647829 |
| 107 | MYLK | 0.44069884 |
| 108 | STK4 | 0.43117689 |
| 109 | PDPK1 | 0.40682286 |
| 110 | PRKG2 | 0.39499943 |
| 111 | STK3 | 0.38846680 |
| 112 | IGF1R | 0.38695159 |
| 113 | PRKCD | 0.37998986 |
| 114 | RET | 0.37255308 |
| 115 | NEK6 | 0.37176919 |
| 116 | PIK3CA | 0.36958944 |
| 117 | ABL2 | 0.36875807 |
| 118 | SIK3 | 0.36872133 |
| 119 | CDK4 | 0.35768601 |
| 120 | TYRO3 | 0.33999293 |
| 121 | PRKD1 | 0.32751951 |
| 122 | FYN | 0.32662701 |
| 123 | PDK1 | 0.31529442 |
| 124 | INSR | 0.30432037 |
| 125 | STK24 | 0.30203371 |
| 126 | SGK3 | 0.29365371 |
| 127 | OBSCN | 0.28496664 |
| 128 | MAP3K1 | 0.27380881 |
| 129 | MAPK12 | 0.26707287 |
| 130 | GRK1 | 0.25145375 |
| 131 | PKN2 | 0.25136152 |
| 132 | SRC | 0.24679271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.94478786 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.91333308 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.88757170 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.59070980 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.47298859 |
| 6 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.46837857 |
| 7 | Malaria_Homo sapiens_hsa05144 | 2.42611654 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.41596403 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.14768698 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.13083510 |
| 11 | Influenza A_Homo sapiens_hsa05164 | 2.06908167 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.01650208 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.99196812 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.93496830 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.88277808 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.87808169 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.85032177 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.78136760 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.70174055 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.66624336 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.65276359 |
| 22 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.59872725 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.56967515 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.53815762 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53412369 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.50537292 |
| 27 | Hepatitis C_Homo sapiens_hsa05160 | 1.50402690 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49024649 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.48845884 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44037955 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42589318 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37673399 |
| 33 | Asthma_Homo sapiens_hsa05310 | 1.35974261 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.33580051 |
| 35 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.32766881 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.30568771 |
| 37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.29502226 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.28000549 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25306854 |
| 40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.24989210 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.23346829 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.22181124 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.20790484 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.19605190 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.19382619 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.19220099 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.13800902 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.11759305 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 1.05938426 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 1.05936373 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.99989383 |
| 52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93517521 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.91901716 |
| 54 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.90549550 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89912880 |
| 56 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87248228 |
| 57 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.85577909 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84593942 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84148978 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.83704980 |
| 61 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.80088485 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75956257 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.75509534 |
| 64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74149029 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73525294 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72809147 |
| 67 | Focal adhesion_Homo sapiens_hsa04510 | 0.71768128 |
| 68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71668911 |
| 69 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71590194 |
| 70 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69815434 |
| 71 | Prostate cancer_Homo sapiens_hsa05215 | 0.69734935 |
| 72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69557250 |
| 73 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.68631575 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66544363 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65213001 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64906082 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64903903 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64194419 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63245803 |
| 80 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.61883065 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60885751 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59984819 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59864042 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59849066 |
| 85 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59421725 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57681774 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57635522 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55512136 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54583097 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.53755844 |
| 91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53359502 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52811242 |
| 93 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52734805 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50474886 |
| 95 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.48261840 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48146217 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48122819 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.48076290 |
| 99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.47843554 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47570019 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47543247 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46702504 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44340693 |
| 104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43803300 |
| 105 | Adherens junction_Homo sapiens_hsa04520 | 0.43310339 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42996362 |
| 107 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42207665 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.39903129 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37860000 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33010436 |
| 111 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.31610613 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31178828 |
| 113 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30336907 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28551555 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.28159298 |
| 116 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28005748 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27790479 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.26993204 |
| 119 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.26792887 |

